Clinical Trial Update: A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a paclitaxel-coated PTCA balloon catheter for in-stent restenosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• Paclitaxel-coated PTCA Balloon Catheter (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: In-Stent Restenosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING